JPS57203011A - Anti-inflammatory external agent - Google Patents

Anti-inflammatory external agent

Info

Publication number
JPS57203011A
JPS57203011A JP8657081A JP8657081A JPS57203011A JP S57203011 A JPS57203011 A JP S57203011A JP 8657081 A JP8657081 A JP 8657081A JP 8657081 A JP8657081 A JP 8657081A JP S57203011 A JPS57203011 A JP S57203011A
Authority
JP
Japan
Prior art keywords
ointment
external agent
drug
agent
inflammatory
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP8657081A
Other languages
Japanese (ja)
Inventor
Kazuo Ohira
Yasuhiro Oshika
Takahito Hasegawa
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Taiyo Pharmaceutical Industry Co Ltd
Original Assignee
Taiyo Pharmaceutical Industry Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Taiyo Pharmaceutical Industry Co Ltd filed Critical Taiyo Pharmaceutical Industry Co Ltd
Priority to JP8657081A priority Critical patent/JPS57203011A/en
Publication of JPS57203011A publication Critical patent/JPS57203011A/en
Pending legal-status Critical Current

Links

Abstract

PURPOSE: The titled external agent, containing 2-[4-(2-thienylcarbonyl)ph]nyl] propionic acid as an active constituent, useful as an anti-inflammatory agent, and having improved percutaneous absorption.
CONSTITUTION: An external agent containing 2-[4-(2-thienylcarbonyl)phenyl] propionic acid expressed by the formula or a salt thereof as an active constituent in the form of an ointment. The compound expressed by the formula has been used as a drug for the internal use of an analgesic and anti-inflammatory agent. The drug for the internal use in once absorbed in the body and then transferred to the blood and the affected part to act thereon. Therefore, much time is required, and the drug concentration acting on the affected part is low to produce only the low remedial effect in comparison with the dose. The resultant external agent is well absorbable through the skin, and exhibits improved anti-inflammatory effects. Preferably, the dosage form is a gel ointment, oily or fatty ointment, water-soluble ointment of emulsion ointment.
COPYRIGHT: (C)1982,JPO&Japio
JP8657081A 1981-06-05 1981-06-05 Anti-inflammatory external agent Pending JPS57203011A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP8657081A JPS57203011A (en) 1981-06-05 1981-06-05 Anti-inflammatory external agent

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP8657081A JPS57203011A (en) 1981-06-05 1981-06-05 Anti-inflammatory external agent

Publications (1)

Publication Number Publication Date
JPS57203011A true JPS57203011A (en) 1982-12-13

Family

ID=13890668

Family Applications (1)

Application Number Title Priority Date Filing Date
JP8657081A Pending JPS57203011A (en) 1981-06-05 1981-06-05 Anti-inflammatory external agent

Country Status (1)

Country Link
JP (1) JPS57203011A (en)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS52145525A (en) * 1976-05-13 1977-12-03 Johnson & Johnson Local antiiinflammation agent
JPS55141407A (en) * 1979-04-11 1980-11-05 Nattermann A & Cie Nonoral administration solution containing arylacetic acid or arylpropionic acid derivative

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS52145525A (en) * 1976-05-13 1977-12-03 Johnson & Johnson Local antiiinflammation agent
JPS55141407A (en) * 1979-04-11 1980-11-05 Nattermann A & Cie Nonoral administration solution containing arylacetic acid or arylpropionic acid derivative

Similar Documents

Publication Publication Date Title
KR880000091A (en) Topical Pharmaceutical Compositions Method of Preparation and Use thereof
CA1202240A (en) Transdermal 2-(4-isobutylphenyl)-propionic acid medication and methods
JPS56100714A (en) Pharmaceutical adhering to oral mucous membrane or nasal mucous membrane
NO166448C (en) ANALOGUE PROCEDURE FOR THE PREPARATION OF THERAPEUTICALLY ACTIVE TIAZOLIDE INDIANS.
ATE15596T1 (en) PHARMACEUTICAL AGENT.
KR910000158A (en) Medicinal Compounds and How to Use Them
ES2033021T3 (en) AGENT WITH DESTRUCTIVE EFFECT TO MALIGNANT TUMORS, PROCEDURE FOR THEIR OBTAINING AND PREPARATION FOR THE APPLICATION IN THE THERAPY OF CANCER PATIENTS.
JPS5551020A (en) Remedy for rheumatism
ATE55248T1 (en) DRUG COMBINATION.
KR960003729A (en) Drugs with antihyperglycemic action
ES2052000T3 (en) PROCEDURE FOR PREPARING PHARMACEUTICAL COMPOSITIONS CONTAINING PENTAMIDINE.
LV11818A (en) A new pharmaceutical composition for the preparation of a stable powder-shaped form
KR880002518A (en) Anti-inflammatory composition
JPS57203011A (en) Anti-inflammatory external agent
NO173137C (en) ANALOGY PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE COMPOUNDS
US4476115A (en) Analgesic composition and method of treating subdermal pain
EP0030023A3 (en) A heterocyclic compound and its synthesis, pharmaceutical formulations thereof and the use of the compounds and the formulations in medicine
CA2038025A1 (en) Optically active alkylenedioxybenzene derivatives and their use in therapy
JPS5562013A (en) Aqueous poultice comprising transcutaneous absorbable anti-inflammatory agent
JPS5562014A (en) Aqueous poultice having no skin irritation effect
KR880004810A (en) Peptic Ulcer Treatment
JPS5675423A (en) Physiologically active high polymer substance-containing composition for mucosa administration and its preparation
JPS643123A (en) Remedy for skin inflammation
JPS57144214A (en) Pharmaceutical preparation for rectum medication
KR900016130A (en) 2-pyridylmethylthio derivatives and ulcer treatments